Ascletis' ASC36_35FDC Shows Promising Results in Weight-Loss Trials at EASD 2026 #Milan #Hong_Kong #Ascletis #ASC36_35FDC #EASD2026

Ascletis' ASC36_35FDC Shows Promising Results in Weight-Loss Trials at EASD 2026 #Milan #Hong_Kong #Ascletis #ASC36_35FDC #EASD2026
Ascletis Launches Phase I Clinical Trial for Novel Obesity Treatment ASC36 in U.S. #USA #N/A #Ascletis #Obesity_Treatment #ASC36
What if the future of weight loss was a monthly shot, *designed by AI*? Ascletis just announced ASC37, a triple